Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma
NCT02561533 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53
Last updated 2017-07-14
Summary
Immunohistochemical detection of the BRAF-V600E mutation on pre-operative fine needle aspiration biopsy (FNAB) from patients suspected for papillary thyroid carcinoma, using the mutation specific antibody VE1.
Conditions
- Papillary Thyroid Carcinoma
Interventions
- OTHER
-
BRAF detection on fine needle aspiration biopsy (FNAB)
Sponsors & Collaborators
-
University of Aarhus
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2017-07-31
- Completion
- 2017-07-31
Countries
- Denmark
Study Locations
More Related Trials
-
ctDNA in Patients With Thyroid Nodules
NCT02778412 ·Status: TERMINATED
-
Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer
NCT05463107 ·Status: ACTIVE_NOT_RECRUITING
-
Proteogenomics for Follicular Cell-derived Thyroid Cancer: Development of a Classification and Prognosis Prediction Model
NCT06969768 ·Status: COMPLETED
-
Aberrant Helix Pomatia Agglutinin Binding Glycan Expression in Follicular Thyroid Tumours
NCT05052359 ·Status: COMPLETED
-
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
NCT01553175 ·Status: COMPLETED
-
Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
NCT01424878 ·Status: COMPLETED
-
Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer
NCT04253106 ·Status: COMPLETED ·Phase: NA
-
Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules
NCT03392402 ·Status: COMPLETED
-
Genomic Predictors of Papillary Microcarcinoma Disease Progression
NCT02363595 ·Status: RECRUITING
-
Hereditary Risk Factors for Thyroid Cancer
NCT02747888 ·Status: RECRUITING ·Phase: NA
-
Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease
NCT01720758 ·Status: COMPLETED
-
Role of NGS-based ThyroSeq Panel in Cancer Diagnosis in Thyroid Nodules
NCT02352766 ·Status: COMPLETED
-
cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project
NCT01543113 ·Status: COMPLETED ·Phase: NA
-
Diagnosing Thyroid Cancer Using a Blood Test
NCT01586520 ·Status: COMPLETED
-
Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection
NCT06895551 ·Status: COMPLETED
-
Epigenetic Regulation of Colorectal Polyps and Cancer
NCT06206603 ·Status: RECRUITING
-
Use of a Liquid Biopsy Signature to Detect Early-onset Gastric Cancer
NCT06023121 ·Status: COMPLETED
-
Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families
NCT00393224 ·Status: TERMINATED
-
MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii
NCT04053114 ·Status: WITHDRAWN
-
Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample
NCT00568438 ·Status: COMPLETED
-
Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor
NCT01453465 ·Status: WITHDRAWN
-
Liquid Biopsy of Head and Neck Cancer Patients in Blood and Saliva
NCT05122507 ·Status: UNKNOWN
-
Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx
NCT00899340 ·Status: COMPLETED
-
Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City
NCT04085900 ·Status: RECRUITING
-
Versatile Ampification Single-Molecule Detection in Liquid Biopsy
NCT05940311 ·Status: RECRUITING